Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw

Japanese Allied Committee on Osteonecrosis of … - Journal of bone and …, 2017 - Springer
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is an intractable, though rare,
complication in cancer patients with bone metastases and patients with osteoporosis who …

Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review

P Wongratwanich, K Shimabukuro… - Dentomaxillofacial …, 2021 - academic.oup.com
Objective: Patients with medication-related osteonecrosis of the jaw (MRONJ) often visit their
dentists at advanced stages and subsequently require treatments that greatly affect quality of …

Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic …

I Ogura, E Kobayashi, K Nakahara, K Igarashi… - Annals of nuclear …, 2019 - Springer
Objective To investigate the quantitative SPECT/CT imaging for medication-related
osteonecrosis of the jaw (MRONJ) using volume-based parameters. Methods Thirteen …

Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences

K Grisar, M Schol, J Schoenaers, T Dormaar… - International journal of …, 2016 - Elsevier
The purpose of this study was to compare medication-related osteonecrosis of the jaw
(MRONJ) with osteoradionecrosis (ORN). Group 1 comprised 74 MRONJ patients (93 …

[图书][B] Raccomandazioni clinico-terapeutiche sull'osteonecrosi delle ossa mascellari (ONJ) farmaco-relata e sua prevenzione

G Campisi, A Bedogni, V Fusco - 2020 - iris.unipa.it
Il trattamento di ONJ è, dalla sua comparsa in letteratura, argomento molto dibattuto, prima,
come osteonecrosi delle ossa mascellari (BRONJ) associata a bisfosfonati (BP) …

A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration

Y Ohbayashi, A Iwasaki, F Nakai, T Mashiba… - Osteoporosis …, 2020 - Springer
We studied the effectiveness of teriparatide (TPTD) for treating medication-related
osteonecrosis of the jaw (MRONJ) in patients with osteoporosis and examined differences in …

Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ)

F Ewald, F Wuesthoff, R Koehnke, RE Friedrich… - Clinical Oral …, 2021 - Springer
Objectives The aim of our study was to describe microbial flora associated with MRONJ and
characterize the susceptibility of pathogens to help guide an effective empiric antibiotic …

The role, efficacy and outcome measures for teriparatide use in the management of medication-related osteonecrosis of the jaw

M Anabtawi, H Tweedale, H Mahmood - International journal of oral and …, 2021 - Elsevier
Medication-related osteonecrosis of the jaw (MRONJ) is a complex disease which can be
associated with multiple morbidities and is challenging to treat. This review evaluates the …

Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings

K Moridera, K Kitajima, K Yoshikawa… - Japanese Journal of …, 2022 - Springer
Objective This study was conducted to investigate the clinical utility of quantitative bone
single-photon computed tomography-computed tomography (SPECT/CT) for detection and …

Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients

H Hata, T Kitao, J Sato, T Asaka, N Ohga… - Scientific Reports, 2020 - nature.com
Abstract Development of quantitative analysis software has enabled application of several
standardised uptake values (SUV) for bone analysis in single photon emission computed …